The Role of Vascular Endothelial Growth Factor (VEGF) in Pathological Angiogenesis and Barrier Breakdown

While essential for development and wound healing, its overexpression in the adult brain is a primary driver of pathological angiogenesis and the breakdown of the BBB. This article explores the biochemical pathways, the root causes of VEGF dysregulation, and the structural consequences of its activity within the CNS.## The Dual Nature of VEGF Vascular Endothelial Growth Factor is a signal protein produced by cells that stimulates the formation of blood vessels. In a physiological context, VEGF is vital. It guides the growth of the vascular system during embryonic development and assists in the repair of tissues following injury. In the brain, low levels of VEGF expression are necessary for maintaining the health of existing endothelial cells.

However, VEGF is also a highly potent inducer of vascular permeability. In fact, it is significantly more powerful than histamine in its ability to make blood vessels 'leak.' This dual role—as a growth factor and a permeability agent—is what makes it so dangerous in the context of disease. When the brain experiences stress, such as ischemia or chronic inflammation, VEGF production is ramped up to dangerous levels, shifting from a restorative signal to a destructive one.## The Architecture of the Blood-Brain Barrier To understand how VEGF breaks down the barrier, we must first look at the barrier's construction. The BBB is not a simple wall but a 'Neurovascular Unit' (NVU) consisting of specialized endothelial cells, pericytes, astrocytes, and a basement membrane. The endothelial cells are fused together by tight junctions (TJs) and adherens junctions (AJs).

These junctions, composed of proteins like Claudin-5, Occludin, and VE-cadherin, act as the 'mortar' between the cellular 'bricks,' preventing the uncontrolled passage of substances into the brain parenchyma. In a healthy state, these junctions are exceptionally tight, maintaining high electrical resistance across the endothelium.## Pathological Angiogenesis: Quantity Over Quality When the brain detects a lack of oxygen (hypoxia), it triggers the production of Hypoxia-Inducible Factor 1-alpha (HIF-1α), which in turn stimulates the massive release of VEGF. The intention is to grow new blood vessels to restore oxygen delivery. This process is known as angiogenesis. However, in pathological states—such as following a stroke or in the vicinity of a brain tumour—the resulting angiogenesis is dysfunctional.

These new vessels are grown too quickly; they are tortuous, fragile, and lack the sophisticated junctional integrity of mature vessels. This 'pathological angiogenesis' results in a network of 'leaky' tubes that fail to provide efficient blood flow while simultaneously allowing plasma proteins and inflammatory cells to flood the brain tissue.## Mechanisms of Barrier Breakdown: The Molecular Cascade The breakdown of the BBB by VEGF occurs through several distinct molecular mechanisms. Primarily, VEGF binds to its receptor, VEGFR2 (Flk-1), located on the surface of endothelial cells. This binding initiates a cascade of intracellular events: 1. Phosphorylation of Junctional Proteins: VEGF signaling triggers the phosphorylation of VE-cadherin, a key component of adherens junctions.

Once phosphorylated, VE-cadherin is internalized (moved from the cell surface to the interior), effectively 'unlocking' the gate between cells. 2. Downregulation of Tight Junctions: Chronic exposure to high VEGF levels leads to a reduced expression of Claudin-5 and Occludin. Without these proteins, the seal between endothelial cells becomes porous. 3. Induction of Fenestrations: In extreme cases, VEGF can induce the formation of fenestrae—tiny holes or windows within the endothelial cell body itself—further increasing the movement of fluid. 4. Increased Transcytosis: Beyond the gaps between cells, VEGF increases 'vesicular transport,' where the endothelial cells actively swallow and transport large molecules across the barrier in a process called transcytosis.## The Root Causes: Why Does VEGF Go Wrong?

At INNERSTANDING, we focus on the root causes of physiological dysfunction. The overproduction of VEGF is rarely a primary event; it is usually a response to underlying systemic or localized stressors. The most common triggers include: - Chronic Hypoxia: Sleep apnoea, cardiovascular disease, or localized ischemia create an environment where cells are starved of oxygen, forcing the constant activation of the HIF-1α/VEGF pathway. - Oxidative Stress: Reactive Oxygen Species (ROS) can directly upregulate VEGF expression and damage the endothelial glycocalyx, making the barrier even more vulnerable to VEGF's effects. - Chronic Inflammation: Pro-inflammatory cytokines like TNF-alpha and IL-6 work synergistically with VEGF, further weakening the tight junctions and recruiting immune cells that release even more VEGF. - Metabolic Dysfunction: Hyperglycaemia (high blood sugar) is known to stimulate VEGF production, which explains the high prevalence of microvascular complications in diabetic patients, including diabetic retinopathy and cognitive decline.## Clinical Consequences: Oedema and Neurodegeneration When VEGF-induced barrier breakdown occurs, the immediate result is vasogenic oedema—the accumulation of fluid in the extracellular space of the brain. This increases intracranial pressure and can lead to further mechanical damage to neurons. Long-term, the 'leaky' barrier allows the entry of neurotoxic substances like fibrinogen and albumin, which trigger microglial activation and chronic neuroinflammation.

This environment is a hallmark of neurodegenerative diseases, including Alzheimer's and Multiple Sclerosis. In these conditions, the constant presence of VEGF prevents the barrier from ever truly healing, creating a vicious cycle of leakage and inflammation.## Conclusion Vascular Endothelial Growth Factor is a master regulator of our vascular system, but its power must be carefully contained. Within the CNS, the transition from physiological repair to pathological destruction is often mediated by the over-expression of VEGF in response to hypoxia and inflammation. By understanding the molecular mechanisms—from the phosphorylation of VE-cadherin to the dissolution of Claudin-5—we gain insight into how to protect the brain's most vital shield. Addressing the root causes of VEGF dysregulation, such as improving oxygenation and reducing systemic oxidative stress, remains a critical frontier in maintaining long-term neurological health and preventing the devastating consequences of Blood-Brain Barrier disruption.